Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada

BACKGROUND: In Canada, discussion about changing from cytology to human papillomavirus (hpv) dna testing for primary screening in cervical cancer is ongoing. However, the Canadian Task Force on Preventive Health Care has not yet made a recommendation, concluding that the evidence is insufficient. ME...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Curr Oncol
Huvudupphovsmän: Popadiuk, C., Gauvreau, C.L., Bhavsar, M., Nadeau, C., Asakawa, K., Flanagan, W.M., Wolfson, M.C., Coldman, A.J., Memon, S., Fitzgerald, N., Lacombe, J., Miller, A.B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Multimed Inc. 2016
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780581/
https://ncbi.nlm.nih.gov/pubmed/26985148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.2991
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk